Table 1.
Comparison of co-morbidities and clinical outcomes in the two groups before and during the pandemic
| Clinical parameters | Cases before the COVID pandemic (2019-2020) (%) | Cases during the COVID pandemic (2020-2021) (%) | P |
|---|---|---|---|
| Age (Mean, Range in years) | 63 (8-75) | 54 (3-71) | 0.007 |
| Gender | |||
| Males | 61 | 63 | 0.019 |
| Females | 39 | 37 | |
| Co-morbidities | |||
| Hypertension | 67 | 65 | 0.622 |
| Diabetes Mellitus | 61 | 63 | 0.588 |
| COPD/Asthma | 32 | 30 | 0.712 |
| CKD | 23 | 18 | 0.421 |
| CLD | 19 | 21 | 0.399 |
| Heart diseases | 11 | 13 | 0.512 |
| Outcomes | |||
| In-patient mortality | 39 | 37 | <0.7 |
| In-hospital stay, in days | 42 (38-56) | 67 (42-89) | <0.001 |
| Infection clearance duration, in days | 21 (17-32) | 35 (29-48) | <0.001 |